Eric Converse

Eric Converse Email and Phone Number

Global Business Builder Driving Shareholder Value - Protecting Investors' Interests - CEO and Board Member (public and private) US/UK/EU @ PreciseDx
Eric Converse's Location
Grand Rapids Metropolitan Area, United States, United States
About Eric Converse

Chief Executive Officer driving shareholder value for multinational US- UK- and EU-based companies with operations spanning Asia, the United Kingdom, Europe, and Australia.Renowned for representing venture capital investors’ interests as a CEO and Board Member for publicand private startup and midcap companies focused on medical device software and technologies forclinical services, clinical research, life science imaging, and healthcare services that deliver patient-specific insights for treatment and improved outcomes.As a forward-thinking business strategist, I have a history of turning around troubled companies anddriving successful outcomes by building the business, financial, and commercial infrastructure, achieving regulatory compliance, and driving business, shareholder, and Board objectives forward.Characterized as a tenacious leader, I am known for building a diverse and inclusive culture of highlyengaged employees committed to the company’s growth. To accomplish this, I have lived and worked in several countries to learn the country's social customs, business environment, and practices.Earlier in my career as a managing director in an international investment firm operating multiple fundsand investments, I concurrently represented the investor’s interest and functioned as CEO and Boardmember.

Eric Converse's Current Company Details
PreciseDx

Precisedx

View
Global Business Builder Driving Shareholder Value - Protecting Investors' Interests - CEO and Board Member (public and private) US/UK/EU
Eric Converse Work Experience Details
  • Precisedx
    Founding Board Member - Former Interim Chair
    Precisedx 2020 - Present
    New York, Ny, Us
    Recruited to represent investors Merck and Philips on the initial Board of Directors established when technology spun out of Mount Sinai.Advise venture-funded (Mount Sinai, Merck GHI, Philips, Agilent, IBM Watson Health (now Merative)) company on cancer risk stratification services for digital pathology commercialization.
  • Amra Medical
    Chief Executive Officer
    Amra Medical 2018 - 2023
    Linköping, Se
    Recruited by this Pfizer Ventures investment to build clinical research and clinical services commercialization for a Linköping, Sweden-headquartered research organization. AMRA Medical is a health informatics company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition analysis, delivering multiple fat and muscle biomarkers with unrivaled accuracy and precision from a rapid whole-body MRI scan.Developed financial and commercial infrastructure, established governance, and recruited senior leaders that transformed this scientific-rooted organization into a regulatory-compliant commercial operation, generating several million annually.Exploited research offering to create a Software as a Medical Device (SaMD) offering with 2 services (BCP Scan and MAsS Scan) using the same product platform, MRI protocol, biomarkers, and workflow, which received FDA clearance. Each product enabled a 95 percent profit margin.Drove awareness and adoption of leading KOLs for both credibility and product development feedback and worked with external consultants to optimize pricing and reimbursement strategy guided by payor interview feedback.
  • Converse And Company, Inc.
    Independent Business Consultant
    Converse And Company, Inc. 2016 - 2018
    Spartanburg, South Carolina, Us
    Advised Merck GHI, the corporate venture capital arm of Merck regarding current and potential portfolio investments and projects dedicated to Real World Data (RWD) and Real-World Evidence (RWE).Conceived and drove strategy to align Merck GHI’s investment strategy with commercial requirements across 3 major divisions to ensure profitable investments and successful corporate collaborations.
  • Virtualscopics
    President & Chief Executive Officer
    Virtualscopics 2013 - 2016
    Rochester, Ny, Us
    VirtualScopics was a publicly traded (NASDAQ: VSCP) imaging Contract Research Organization (iCRO) that sold to BioTelemetry (NASDAQ: BEAT) in 2016, which is now a part of ICON plc.Recruited by the minority owner, Merck GHI, to join the Board and subsequently assume the CEO role for this imaging Contract Research Organization.• Redefined research services offering into a narrowly focused profitable strategy and established FDA regulatory-compliant infrastructure. • Increased sales 4-fold by developing a focused strategy (oncology and muscular/skeletal), revamping sales processes, improving service performance, and gaining customer trust. Drove sales from $7.5 million to $30 million. Sold to BioTelemetry (NASDAQ: BEAT) for $15.5 million. • Slashed $2 million/year burn rate by aligning operations and R&D teams and driving an initiative to cost projects before bid and enforce department head sign-off.• Restructured, built, and scaled a 105-employee workforce aligned with the company's growth phase while generating increased profits.• Led development of FDA-compliant structure and passed first FDA audit with zero observations.• Drove win rates for sales through a billion-dollar CRO partner from 5 percent to 40 percent.
  • Nedamco Capital
    Managing Partner
    Nedamco Capital 2002 - 2014
    Nedamco Capital is a privately held international investment firm based in Bloemendaal, the Netherlands, that operated 8 funds with 50 investments and $800 million invested capital.As Managing Director, represented Nedamco’s interests through CEO and Board leadership roles across portfolio investments. Highlights include: • Board Member, CymaBay Therapeutics, Newark, CA (2011–2013) Clinical stage biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases. 2014 IPO raised $263.57M.• Vice Chairman Board of Directors, Swyx Solutions AG, Dortmund, Germany (2010-2013)Major Investor: Deutsche Telecom — Sold to Waterland Private Equity Investments B.V.• CEO, Oblicore, Waltham, MA, Belgium & Israel (2008-2010), $20M Contract Management Software company — Sold to CA Technologies (NASDAQ: CA)• CEO, Oneswoop.com, Liverpool, UK — Sold to Norwich Union/Aviva Group (LSE: AV.L) (2002-2004)• Concurrently, instrumental is transforming Nedamco from a partnership fund to a family office using evergreen funds.
  • Cymabay Therapeutics
    Board Member
    Cymabay Therapeutics 2011 - 2013
    Newark, California, Us
  • Swyx
    Board Member - Vice Chairman
    Swyx 2010 - 2013
    Dortmund, De
    Develops communication software specifically tailored for small to medium-sized companies. $40 million revenues with 100 employees. Major investor/customer Deutsche Telecom.
  • Oblicore
    Ceo / Board Of Directors
    Oblicore 2008 - 2010
    Us
    $20M Contract Management Software for Telecom, Banking and Auto industries. 5 offices worldwide. 100 employees. Sold to CA Technologies (NASDAQ: CA)

Eric Converse Education Details

  • Michigan State University
    Michigan State University
    General Business Administration

Frequently Asked Questions about Eric Converse

What company does Eric Converse work for?

Eric Converse works for Precisedx

What is Eric Converse's role at the current company?

Eric Converse's current role is Global Business Builder Driving Shareholder Value - Protecting Investors' Interests - CEO and Board Member (public and private) US/UK/EU.

What schools did Eric Converse attend?

Eric Converse attended Michigan State University.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.